An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion

References

1. Burgstaller P., Jenne A., Blind M. 2002; Aptamers and aptazymes: accelerating small molecule drug discovery. Curr Opin Drug Discov Devel 5:690–700
   [Google Scholar]
2. Clark S. L., Remcho V. T. 2002; Aptamers as analytical reagents. Electrophoresis 23:1335–1340 [CrossRef]
   [Google Scholar]
3. Georgiou G. N., Morrison I. E. G., Cherry R. J. 1989; Digital fluorescence imaging of fusion of influenza virus with erythrocytes. FEBS Lett 250:487–492 [CrossRef]
   [Google Scholar]
4. Göringer H. U., Homann M., Lorger M. 2003; In vitro selection of high-affinity nucleic acid ligands to parasite target molecules. Int J Parasitol 33:1309–1317 [CrossRef]
   [Google Scholar]
5. Hall T. A. 1999; BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
   [Google Scholar]
6. Hoekstra D., de Boer T., Klappe K., Wilschut J. 1984; Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675–5681 [CrossRef]
   [Google Scholar]
7. Jenison R. D., Gill S. C., Pardi A., Polisky B. 1994; High-resolution molecular discrimination by RNA. Science 263:1425–1429 [CrossRef]
   [Google Scholar]
8. Jeon S. H., Kayhan B., Ben-Yedidia T., Arnon R. 2004; A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem 279:48410–48419 [CrossRef]
   [Google Scholar]
9. Knight R., Birmingham A., Yarus M. 2004; BayesFold: rational 2° folds that combine thermodynamic, covariation, and chemical data for aligned RNA sequences. RNA 10:1323–1336 [CrossRef]
   [Google Scholar]
10. Kobasa D., Takada A., Shinya K. & 16 other authors 2004; Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703–707 [CrossRef]
    [Google Scholar]
11. Kumar P. K. R., Machida K., Urvil P. T., Kakiuchi N., Vishnuvardhan D., Shimotohno K., Taira K., Nishikawa S. 1997; Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237:270–282 [CrossRef]
    [Google Scholar]
12. Kumarevel T., Mizuno H., Kumar P. K. R. 2005; Structural basis of HutP-mediated anti-termination and roles of the Mg²⁺ ion and l-histidine ligand. Nature 434:183–191 [CrossRef]
    [Google Scholar]
13. Lowy R. J., Sarkar D. P., Chen Y., Blumenthal R. 1990; Observation of single influenza virus–cell fusion and measurement by fluorescence video microscopy. Proc Natl Acad Sci U S A 87:1850–1854 [CrossRef]
    [Google Scholar]
14. Matsugami A., Kobayashi S., Ouhashi K., Uesugi S., Yamamoto R., Taira K., Nishikawa S., Kumar P. K. R., Katahira M. 2003; Structural basis of the highly efficient trapping of the HIV Tat protein by an RNA aptamer. Structure 11:533–545 [CrossRef]
    [Google Scholar]
15. Misono T. S., Kumar P. K. R. 2005; Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem 342:312–317 [CrossRef]
    [Google Scholar]
16. Mizuno T., Kawasaki K., Miyamoto H. 1992; Construction of a thermotaxis chamber providing spatial or temporal thermal gradients monitored by an infrared video camera system. Anal Biochem 207:208–213 [CrossRef]
    [Google Scholar]
17. Nimjee S. M., Rusconi C. P., Sullenger B. A. 2005; Aptamers: an emerging class of therapeutics. Annu Rev Med 56:555–583 [CrossRef]
    [Google Scholar]
18. Osborne S. E., Matsumura I., Ellington A. D. 1997; Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr Opin Chem Biol 1:5–9 [CrossRef]
    [Google Scholar]
19. Skehel J. J., Wiley D. C. 2000; Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569 [CrossRef]
    [Google Scholar]